Healthcare Startups funded by Y Combinator (YC) 2025

Ginkgo Bioworks is the organism company. We design custom organisms for customers across multiple markets. We build our foundries to scale the process of organism engineering using software and hardware automation. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology.

We make oral drugs to treat and prevent viral infections - like COVID-19.

Diassess Inc. is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the world.

Nurx is a telemedicine startup focused on increasing access to healthcare, starting with birth control and PrEP services.

We're a women’s health company making personalized reproductive health information more accessible, earlier in life. We make the same laboratory tests that were previously confined to fertility clinics more accessible for women at home. By arming women with powerful information about their reproductive health, Modern Fertility is closing the fertility information gap and enabling women to own the decisions impacting their bodies and futures. We've raised $22 million from Forerunner Ventures, Maveron, Union Square Ventures, First Round Capital, #Angels and Y Combinator.

DrChrono develops the essential platform and services for modern medical practices to make care more informed, more interactive, and more personalized. The open platform powers telehealth, electronic health record (EHR), practice management, medical billing, and revenue cycle solutions for physicians and patients, and is fully extensible via a robust API and marketplace of applications and services. The platform is used by thousands of physicians and millions of patients, and is facilitating millions of patient appointments and is processing billions of dollars in medical billing. For more information about DrChrono, visit www.drchrono.com

Helium Health provides a suite of digital health tools for healthcare providers, payers and patients across Africa — most prominent of which is our maiden electronic medical records (EMR) & hospital management information system (HMIS) for emerging markets, HeliumOS. We offer business loans to healthcare providers through our HeliumCredit product. We also work with donors and governments in executing public health strategies. Finally, we have built the largest healthcare data repository on Africans with over 1 million health records.

Bodyport’s cardiovascular sensing weight scale and predictive algorithms detect early changes in cardiac function to help prevent avoidable hospitalizations. Bodyport is initially targeting heart failure, a chronic condition affecting over 6M Americans and a leading cause of hospitalizations (1M/year) and healthcare spending ($35B/year). Bodyport’s novel scale measures cardiac output, congestion, heart rate, and other leading indicators of cardiovascular health — all in the same step patients already take to weigh themselves. Companion algorithms and software empower care teams to quickly identify at-risk patients and remotely optimize their therapy to prevent deterioration.

BIOS Health was previously called Cambridge Bio-Augmentation Systems (CBAS) and focused on prosthetic neural interfaces as a first market. Now we use

Today's funders are so conservative they only fund the most obvious ideas. At Experiment, we fund the ideas that they won't fund; the ideas that matter. Since founding, over 47,000 citizens have pledged $9 million dollars supporting 900 scientific projects on the platform. 46% of all projects on Experiment are successfully funded. When the projects are finished, the scientists share the scientific results with their backers as lab notes and peer-reviewed publications. Scientists from Stanford, Harvard, and Yale have chosen to use Experiment instead of writing grants. Bill Gates recognized Experiment by saying "this solution helps close the gap for potentially-promising but unfunded projects."

HistoWiz is an innovative company dedicated to accelerating pathology-based research. HistoWiz provides fast, global access to digital whole-slide images, online collaboration tools, low-cost data management, and experimental pathology expertise. The web-based platform accelerates information exchange among medical scientists and research pathologists. HistoWiz's mission is to fight cancer cooperatively instead of individually by connecting scientists and pathologists for online collaboration. The HistoWiz advantage We help your lab minimize the cost of research and maximize research productivity by providing the most efficient service for scientists to analyze experimental pathology specimens. We believe that scientists should spend their time on results interpretation rather than repetitive tissue cutting. How does it work? HistoWiz accepts formalin-fixed specimens by mail for tissue processing services. To expedite delivery of results and to facilitate global collaboration, HistoWiz offers whole-slide imaging and pathology services, allowing researchers to remotely and instantly view high-magnification images of their specimens via a secure, cloud-based “virtual microscope” on any computer or mobile device without downloading any software or gigabyte-sized files.

Nectome is a neuroscience startup that aims to preserve the brain and keep all its memories intact. The company is building the next generation of tools to preserve the connectome. The connectome is all the connections called synapses between neurons in the brain. Researchers from the company is now learning to manipulate individual memories, building advanced brain prosthetics, and reverse-engineering the brain.

Syrona Health’s innovative insurance rider is designed to address the critical gaps in women’s health coverage by integrating fertility, menopause, and female-specific cancer care into term and life insurance for employers. Our solution directly tackles the escalating $30B in out-of-pocket healthcare costs by offering financial protection for treatments often excluded or poorly covered by traditional health insurance.

Humane Genomics has developed a platform to engineer cancer killing viruses. We have taken a first principles approach to design and make oncolytic viral therapies. Using a highly lytic RNA virus engineered with "2 factor authentication" (using selective infection and selective replication) they have an on-target to off-target kill ratio > 1000. We are working on our first indication, pediatric liver cancer (hepatoblastoma), with our partners at Texas Children's Hospital, who are world leading experts. We have in vivo (mouse) data showing safety and currently developing efficacy data and are showing 50% reduction in tumor volume.

C16 Biosciences is decarbonizing consumer products supply chains by producing next-generation ingredients. The company's biomanufacturing platform produces better performing, more sustainable alternatives to oils and fats, and their first product is an alternative to palm oil. The company owns and operates Palmless™ alternative fats and oils.

If you're a YC company: Book Here! Calendly.com/ichra-vitablehealth We are a team of engineers, clinicians, and operators rethinking healthcare for startups and and SMB's. We make it simple for startups to offer ICHRA with built in direct primary care, including free virtual visits, over 1,000 prescriptions, and 40+ lab tests. Contributions are made with tax-free dollars, and we handle everything from onboarding to ongoing care so founders can stay focused on building. We are backed by world class investors like First Round Capital, Cherryrock, Y Combinator, and SoftBank, along with incredible founders and operators including Michael Seibel (YC, Twitch), Immad Akhund (Mercury), Allison Pickens (Gainsight), Jack Altman (Lattice), Dan Folkman (GoPuff), and others.

Eugit Therapeutics targets the issue of non-specific drugs that cause toxicity and clinical trial failures, affecting millions with tissue-specific inflammatory diseases. TAGHOME delivers drugs with precision to diseased tissues using T cell receptors, enhancing safety and improving efficacy. Our initial focus is on the 3.1 million U.S. individuals with Inflammatory Bowel Disease, aiming to initiate clinical trials within two years. Cofounded by George Church (Harvard) and funded by Y Combinator (S22).

Overdrive Health offers AI powered medical billing services, helping providers get paid more money in less time. Our technology enables us to provide the best quality insurance and patient billing services for a fraction of the usual cost

38 million people suffer from heart rhythm disorders and are recommended to start medications that can save their lives, but require rigorous ECG monitoring to start and remain on these pills. SafeBeat Rx moves beyond diagnostics to guide these therapeutics, powered by our ML ECG software that integrates with existing FDA-cleared wearables to allow seamless physician approval of drug dosing, all from a mobile phone. We are a team of physicians, engineers, data scientists, and machine learning experts dedicated to using engineering to improve heart health.

Understand & control neural syntax.

Parachute helps hospitals adopt AI safely and at scale. We vet AI tools that fill clinical gaps, run state-of-the-art evaluations, monitor every model for drift and compliance, and lock every decision in an immutable audit trail.

If we've learned anything in the last few years it's that spending time with our friends and family is essential to our well-being and happiness. Unfortunately, loud and noisy places like weddings and family gatherings hinder human connection, especially for the hearing impaired. In fact, the biggest unmet need in the entire hearing healthcare industry is hearing in noisy places. AudioFocus helps patients hear in these environments by only enhancing voices nearby the patients and ignoring ones farther away. We do this using acoustics informed machine learning and custom microphone array design. Our goal is to increase the adoption rate of 37M US adults with hearing loss, only 8M use hearing aids today. Founded by Auditory Neuroscientist & AI expert and a Hearing Aid hardware design expert.

HealthSpark empowers physical therapists (PTs) to start, run, and grow their own independent practices. Our AI-native “business-in-a-box” takes care of the administrative work—credentialing, insurance billing, patient onboarding, documentation, and scheduling—so PTs can focus on patient care, not paperwork.

Solugen is decarbonizing the chemistry of everyday life with enzymes and innovative metal catalysts. Our new to the world Bioforge platform technology can produce high value chemical goods that are biobased and carbon negative, at cost on par with current technologies. We are making sustainable chemistry accessible to all living things, to ensure a prosperous world exists for generations.

Starling is building a urine diagnostic remote patient monitoring platform that seamlessly integrates into anyone's bathroom routine. By detecting early changes in a patient's urine using our toilet indwelling mass spectroscopy device, our platform is aiming to prevent hospitalizations from numerous conditions like recurrent UTIs, BPH exacerbations, or diabetes. We do this while creating significant new annual revenues for our clinician partners from remote patient monitoring reimbursements without requiring any significant changes in a staff's day to day schedule.

We are a service for people to learn about their personal environmental exposures. Our first product is a urine test for exposure to chemicals in everyday products.

TYBR is developing a hydrogel to limit internal scarring after surgery. The naturally derived material is applied to coat tendons at the end of surgery to improve healing outcomes for the millions Americans who undergo tendon or ligament surgery each year.

At Verse Therapy, we're dedicated to making quality speech therapy accessible for everyone by empowering speech-language pathologists (SLPs) to launch and grow their own independent practices. We help therapists focus on what they do best—providing compassionate, personalized care—by taking care of the administrative tasks that often lead to burnout. Through thoughtful marketing and partnerships with care organizations like rehab centers, we connect SLPs with individuals who need their expertise. Our AI-enabled back office streamlines insurance processing, scheduling, and documentation, reducing non-therapy overhead. We're now live in 10 states with over 35 dedicated therapists and are in-network with leading insurance providers, making it easier for clients to receive the support they need.

Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material. Our killer application is enabling the newest generation of synthetic bacteriophages to combat antibiotic-resistant infections, which are threatening to cause more deaths than all cancers combined.

TrueClaim processes all payments between healthcare providers and companies that self-fund their insurance. TrueClaim's AI-enabled engine adjudicates and continuously reviews 100% of medical claims to save at least 7% of healthcare costs.

Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. Our veterinary partners have treated thousands of dogs over the past 30 years and work closely with the growing FidoCure® network of over 143 clinics and 180 forward-thinking veterinary oncologists throughout the US. Together, we can combat canine cancer!

MentalHappy is a secure and compliant platform that leverages AI and data-driven analytics to enhance the group-based therapy experience and boost client/patient engagement. Our platform streamlines administrative tasks for providers, improves group participant self-management capabilities, automates group participant check-ins, and identifies group members who may be at risk. Additional features on the platform allow providers to schedule and host virtual sessions, engage members in secure chat, and share health resources, and offer support groups

CareMessage is the technology non-profit building the largest patient engagement platform for low-income populations in the United States. Powered by the Health Equity Engine™, the platform enables organizations to combine messaging, data, and interoperability to increase access to care, improve clinical outcomes, and address social drivers of health. With 20 million patients reached since 2013, CareMessage is the only patient engagement solution proven to improve health equity at scale. The team, many with lived experiences in these communities, leverages a nonprofit model to reinvest revenue into impact. CareMessage is the partner of choice for organizations committed to advancing health equity.

Dear Brightly offers prescription skin products online. Our mission is to get people access to the most effective, dermatologist vetted skincare products for healthy skin, using technology.

As healthcare costs have increased, the patient's home has become incredibly important as a site of care. Yet, patients recovering at home are highly underserved. Patients can only get better at home if they receive the high-quality care that they need reliably. The existing in-home care process involves patchwork of different vendors, all connected through faxes by nurses. We're building modern, robust software that solves this challenge and brings this market online.

Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models.

Our AI-powered healthcare information platform leverages LLMs to deliver accurate, up-to-date medical knowledge

BitBoard lets healthcare providers hire AI agents for repetitive administrative work within their existing tools and systems. BitBoard agents are already recovering thousands of hours previously spent on tedious tasks like reviewing intake forms and updating patient charts. The founders were early employees at Forward, where they delivered primary care across the US with support from thousands of remote contractors handling manual administrative tasks. AI agents are finally capable enough to help.

Current Description: RTHM provides virtual-first care for complex illness including Long COVID, ME/CFS, POTS, and mast cell activation. Many clinics focus on teaching patients how to better cope with symptoms, which is helpful, but we don’t stop there. We develop collaborations & partnerships so our patients access to the most promising testing and root-cause directed early therapies for their illness(es) with the goal of simplifying and streamlining the most efficient and effective clinical pathways so they can be scaled in the form of low cost online modules overseen remotely by clinicians. In conjunction with clinical care, RTHM operates a clinical lab and collects deep molecular data with robust clinical context to develop AI-powered diagnostics and better ways of predicting which treatments may work best for whom.

Fortuna is a one-stop solution that helps consumers navigate Medicaid end-to-end from eligibility and enrollment to renewing coverage. Our platform creates value as the middleware layer for the $800B Medicaid ecosystem.

ZBiotics is a synthetic biology company founded in 2016 and headquartered in San Francisco, California. The company bioengineers probiotic bacteria for nutraceutical and other applications. They launched the world's first genetically engineered probiotic in 2019 – a probiotic that breaks down a toxic byproduct of alcohol. They are currently developing a pipeline of additional engineered probiotics for other consumer health applications.

Andson Biotech helps pharmaceutical companies measure difficult to detect chemicals that they need to measure while developing and manufacturing drugs like cell-therapies or biologics. Drug companies want to use our technologies to get fast and accurate chemical measurements they do thousands of times per day for drug development and quality control.

Menten AI designs protein drugs and enzymes using quantum computing and machine learning. Their technology leapfrogs current computational methods making it possible to design previously intractable proteins. The team created the first protein design algorithm for current and near-term quantum computers and created the world’s first protein designed on a quantum computer. They are now working on 3 new proteins, including a peptide to prevent the spread of viruses like Covid-19. They have 2 paid pilot projects with multinational chemical companies and 4 LOI’s with pharma and biotech companies.

Breathe Well-being helps people prevent or manage chronic lifestyle diseases by losing weight through its digital therapeutics program (weight-loss clinic in a cloud, think Noom for India). The program is delivered remotely over the phone and through the mobile app, therefore users are able to follow the lifestyle program from the convenience of their home. Our online program is 3X more effective at 1/4th the cost. The user receives bi-weekly 1-1 coaching focused on behavioral changes, online community for support and motivation, and a mobile app that provides educational lessons, lifestyle tracking tools and weekly challenges (gamification). The content and behavioral change techniques are centred around healthy diet, fitness, lifestyle and stress reduction. Our unique coaching methodology employs cognitive behavioral therapy (CBT), goal-oriented treatment and self-efficacy enhancement. The coach helps the user bust negative emotions of past failures in weight-loss and increase motivation by linking short-term achievable goals with the user's personal values. Through the program, the user is able to self-identify triggers of unhealthy habit adoption and make better decisions. Breathe Well-being has demonstrated success in helping people lose weight, build long-term healthy habits and reduce/eliminate medication for lifestyle diseases (example - Type 2 Diabetes). We are looking for ideas to improve our sales processes so that we can get users to enrol at a higher conversion rate post our 1-week free trial. We need to identify triggers when users are most likely to pay and provide them with a seamless process for paying on-the-spot.

We are a nonprofit stool bank, expanding safe access to fecal transplants and catalyzing research on the human microbiome.

ParcelBio is delivering the next generation of RNA medicines.

At CellChorus, we apply artificial intelligence to evaluate thousands of microscopy videos in parallel to evaluate how immune cells move, interact and perform over time. This allows our customers to discover, develop, manufacture and deliver cell therapies, antibodies, vaccines and other novel therapies faster, at lower expense, and with higher rates of success. Our customers include top-25 biopharma companies and seed-stage biotechs that are developing cell therapies, antibody therapeutics and vaccines (including one of the few companies with an approved CAR T cell therapy). Hear from the team at https://www.youtube.com/watch?v=IE9x_tm0XnI

Junction Bioscience is building an autonomous AI scientist to navigate the discovery of transformative medicines. Our scientific hypothesis engine iterates upon breakthrough chemistry from the laboratory to achieve clarity and control over the molecular basis of disease. We focus on the intersection of neuroinflammation and immunology where uncommon molecular insights position us to develop best-in-class therapies for millions of patients in need.

Nori takes *all* of your health data—Apple Health, Oura, Whoop, Peloton, nutrition apps, Garmin, MyChart, blood tests from Function Health, Superpower—all feeding your personal health AI. With Nori, you get health advice that's personalized to you, practical and achievable, and based on proven, evidence-backed approaches. Who it’s for: People who want weight loss, better energy, or faster recovery—starting with iOS users

Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.

NearWave makes a handheld imaging device that helps physicians select the right therapy for their breast cancer patients. This prevents patients from suffering through months of side effects caused by unsuccessful treatments.

Kabilah is the most trusted enterprise-grade AI platform designed specifically for nursing workflows. We reduce burnout, enhance system efficiency, and enable high quality care.

Arpeggio Bio is a pioneering pharmaceutical company that develops drugs targeting transcription factors using AI and high-throughput RNA-sequencing. With $20M in venture funding, we've targeted "undruggable" proteins like NRF2, TEAD, and GPX4 where our lead program is rapidly progressing towards a DC for the treatment of IO-resistant melanoma. With partnerships with J&J and FORMA, we've validated our platform in rare disease and inflammation with a significant Phase I success.

Trapeze empowers doctors to answer patient calls 24/7 with our voice agents clones of their best call center reps and receptionists. In the past 3 months, we’ve onboarded 140+ doctors nationwide serving 1,000,000+ patients. We're building the AI-native Zocdoc to create the standard for how patients and providers find each other. Follow along on the BTS of our journey: https://www.tiktok.com/t/ZTjQyxEQx/

Founded in 2022 and based in San Diego, California, Cisterna Biologics is a technology company. It aims to solve some of the challenges currently facing the biotech industry to develop mRNA-based therapeutics – quality, quantity, longevity and cost of mRNA. As mRNA technology matures, it becomes imperative that these issues are solved so we can fully explore mRNA's endless possibilities as a therapeutic. Cisterna uses proprietary technologies to either remove a contaminant at its source or replace the source itself. For example, to remove double-stranded RNA (dsRNA), we use ribozymes - molecular scissors - to precisely cut the mRNA at its 3’ end. This assures not only 3’ homogeneity, but also eliminates dsRNA, which are primarily produced due to self-templated additions at the 3’ end. Utilizing a PCR-like system to amplify the DNA template in large quantities eliminates the requirement for plasmid enrichment in bacteria, the prime source of endotoxin contamination. These are just a few examples of Cisterna’s powerful technologies being used to achieve our goal of 10x higher quality mRNA for therapeutic application.

We're making every therapeutically valuable emotion available on demand in pharmaceutical form. Our Osmanthus platform is an ensemble of AI models that synthesize the world’s largest datasets of psychoactive pharmacology and phenomenology, quantitatively pinpointing the combination of neurotransmitter receptor activity that underlies various emotional as well as cognitive and perceptual states. Our lead program MSD-001 is designed to be rapid-acting and produce heightened emotional and cognitive flexibility without hallucinations. MSD-001 is currently in human trials, and will be the base ingredient for multiple drug combination "emotions in a bottle" such as empathy, awe, clarity, or beauty.

Catena’s technology lets us attach any two proteins together using an enzyme and the native amino acids tyrosine and cysteine within target proteins. It is a true platform technology because it enables the joining of any two soluble proteins together with minimal engineering and without restrictions due to protein size or complexity. Our work has already been used to modify cancer specific antibodies, CRISPR proteins and even cell surfaces. Our ability to produce modular protein therapeutics in a fraction of the time allows for true library creation across the therapeutics spectrum from oncology, vaccines, inflammatory disease and beyond.

Diffuse is building generative AI for protein design. Our mission is to build AI systems that engineer new and useful proteins with unprecedented control and accuracy. Our team has been behind breakthroughs in AI protein design for the past 7 years, including the first experimental validation of AI-generated proteins and diffusion models for protein structure and sequence.

The Human Diagnosis Project (also referred to as “Human Dx” or “the Project”) is a worldwide effort to build an open medical intelligence system that maps the steps to help any patient. By combining collective intelligence with machine learning, Human Dx intends to enable more accurate, affordable, and accessible care for all

We make it easy for anyone in India to access healthcare over Zoom, Meet, or WhatsApp. We provide care in 11 local languages. For every appointment, we provide a concierge who manages all logistics for the patient & handles the back-office work for doctors. With this, we have cracked the code to make telehealth work in India.

Intellect is the global leader in hyperlocalised mental healthcare, serving 4 million lives across enterprise employers, insurers, healthcare systems, and governments in over 50 languages and 100 countries. With a comprehensive, AI-powered care ecosystem, Intellect seamlessly integrates digital therapeutics, virtual therapy, high-acuity crisis support, and specialty clinical treatment - delivered through its proprietary digital platforms and directly owned mental health clinics. Headquartered in Singapore with nine global offices, Intellect is backed by top investors including Tiger Global, Y Combinator, Insignia Ventures, and HOF Capital. It is trusted by hundreds of Fortune 500 companies and industry leading organisations.

Finding new cures requires seeing what and where the abnormal molecules are in a diseased tissue, but current tools see less than 1% of those molecules. Biocartesian combines microscopy and new chemistries to see 50X more, offering unprecedented insights into disease biology and new therapies.

MetricWire’s mobile platform allows decision makers, researchers, and stakeholders to harness unparalleled insights solutions, analytical tools, and deeper audience connections. Our innovation has lead to real-time digital interventions, enriched research, and evidence-based decisions. Capture more powerful data and make better decisions

Brown Foods is a Stanford, Rice University and IIT Delhi alumni venture building the next-generation of food products. They are creating UnReal Milk- lab based, clean milk - extremely sustainable 'real milk' but made without any cows. Unlike any other option in the USD 22 billion dairy alternatives market today, it will be exactly similar to cow’s milk in terms of nutritional profile, taste, texture and could also be processed into butter, cheese and ice creams. They envision to disrupt the USD 700 billion conventional dairy market by giving the world its 1st 'cow free' real milk option, reducing the carbon footprint of milk by over 90% while being completely cruelty-free.

Culture Biosciences grows cells for biotech companies. Our customers genetically modify organisms to produce new therapeutics, materials, fuels and foods. We help them quickly run experiments and develop manufacturing processes so they can get their products to market faster. We've built proprietary software and automation systems to make operating our bioreactors more efficient than existing systems. We also provide customers with new software tools that help them analyze and contextualize their data. We are currently serving a number of biotech customers and scaling out our infrastructure.

Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.

At Ember, we're tackling one of healthcare's most costly and overlooked challenges: the massive inefficiency in clinical documentation and revenue cycle management. Medical practices lose billions annually due to incomplete documentation, missed billing opportunities, and denied claims - issues that stem from antiquated systems that force clinicians to choose between patient care and paperwork. We combine ambient listening technology with deep understanding of medical billing requirements to eliminate the administrative burden that plagues healthcare providers.

Design, simulate, and test your proteins 100x faster with the end-to-end no-code platform for protein engineering. Powered by Amina, our AI agent. With Amina, one protein engineer can do the work of 10. Describe what you want to achieve and Amina will handle everything else – from research and design to simulation, folding, docking, and protein characterization. It asks clarifying questions if needed, intelligently understands and performs the task, and analyzes your results within the context of your project.

Have you ever wondered why it's so hard for physicians to communicate quickly and why the leading cause of preventable death is still a delay in communication? Our team has built the solution for this. Medigram is a team of tier 1 health system CxO IT executives, technologists, SaaS exec, physicians, engineers, and data experts. We have developed a breakthrough service for the medical industry to save lives and for hospitals to make millions per year. Medigram instantly flags insights from clinician chats for immediate insight into hospital operations and patient care. This reduces critical response times by 50%. We've designed this system to provide instant, reliable messaging (including images and audio files) across very complicated network environments in hospitals. Medigram is secure, designed for HIPAA, and a full stack system which includes database back end, middleware, logic, and client apps for iOS, Android, desktop, and the web. Our solution to this is Mobile Intelligence For Healthcare by providing a secure, intelligent workflow management platform for the patient care ecosystem and medical professionals. Within the healthcare environment, you have physicians, the patient care team, EMR, workflow, data, and administration which needs to be tied together with intelligence through Medigram.

Delivery of TERT mRNA extends telomeres sufficiently in a few days to reverse over a decade of telomere shortening during normal aging. We are advancing TERT mRNA-based therapies to the clinic.

The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up. Our VectorSelect platform is designed to unlock the scale these therapies need to survive. We combine massively parallelized screens with computational insights to engineer high yield cell lines and production technologies — accelerating the manufacturing of advanced therapies from the inside out.

We’re building the AI workforce for healthcare clinics, starting with mental health. Our AI Admissions Coordinator, Sarah, manages the first patient touchpoint via phone, text, or referrals. Available 24/7, she responds instantly and increases new patient bookings by up to 30%. Our AI Clinical Assistant, Emma, automates the paperwork and administrative tasks before, during, and after each session, so clinicians can focus fully on patient care.

H1 helps connect the healthcare ecosystem by providing a global platform of every healthcare professional and healthcare organization.

Our compounds disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the tumor microenvironment. By impacting multiple cell types, we are enabling effective, lasting cancer treatments.

Future Fields has developed the world's first multicellular advanced biomanufacturing platform for the production of the most challenging recombinant proteins. We help companies in biotech, life sciences, and pharma by manufacturing their proteins.

We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.

CoreCare is the leading AI-powered workflow platform helping Post-Acute and Long-Term Care (PALTC) providers achieve operational excellence. Trusted by 1,000+ locations nationwide, CoreCare increases admissions, optimizes reimbursement rates, improves collection metrics, and reduces administrative burdens—all on one intuitive platform. At the heart of CoreCare is Collaborative Revenue Management, which unites essential data and teams on a shared platform. Our approach empowers employees—regardless of skill or tenure—to perform like experts from day one, collaborate with their peers on critical work, and give management unmatched visibility into performance across the organization. CoreCare replaces error-prone spreadsheets and fragmented portals with streamlined workflows that drive measurable results. Trusted by leading providers, CoreCare redefines how teams work and sets a new standard for AI in long-term care.

Adoption of Telehealth 1.0 has dropped to <5% because it's inefficient and unintelligent. Ankr uses generative AI to recreate functions of clinic staff including front desk, medical assistants and scribe. This allows Doctors to "spin-up" virtual clinics on-demand, anytime, anywhere. An average clinic using Ankr generates $1M in new revenue/year. We integrate with all top EHRs and work with all types of clinics in mid- to large-sized healthcare organizations.

Morf is an integration platform that allows healthcare providers to sync patient data and automate workflows across their tools. For example, when a patient submits an intake form, Morf creates a patient record in an EHR and sends insurance information for an eligibility check. You can think about it like Segment + Zapier for healthcare providers. Morf helps their customers eliminate tedious administrative tasks and empowers them to focus on patient care as they grow.

Our mission is to improve quality of life for millions of people by providing easy, immediate access to the world’s best sleep care. Sleep Reset is a digital, personalized sleep clinic, available in a convenient mobile app for iOS and Android. Our program was designed in partnership with leading sleep experts from top sleep clinics and universities. The program improves sleep and reduces sleep anxiety with the most effective methods from sleep clinics, including strategies based on Cognitive Behavioral Therapy for Insomnia (CBT-i) which are proven to be more effective than sleeping pills. Throughout our program, each member is paired with a dedicated sleep coach who personalizes their program. It’s a life-long, sustainable solution to sleep better in weeks, with no pills or melatonin needed – which means no grogginess, side effects, or dependency. Sleep Reset has been covered in Forbes, TechCrunch, and INSIDER. The company was founded by Yunha Kim, a serial entrepreneur recognized by Forbes as 30 Under 30 and is backed by top Silicon Valley investors including YCombinator, Foundation Capital, New Enterprise Associates, Stanford University and 20+ founders/executives of leading companies.

Delfino AI helps automate the repetitive phone calls that providers' offices make to payors

Our AI browser assistant automates insurance tasks like verifying benefits, submitting prior auths, checking claim statuses, and more across all payer portals, directly from the clinic's EHR. It does exactly what the admin team is doing today, just helps them do it 10x faster and as thoroughly as a seasoned teammate.

Carrot is a simple and affordable way for companies of any size to build or enhance their fertility benefit. Carrot can help with egg freezing, infertility treatments including in vitro fertilization (IVF), LGBT+ conception, and more. Fertility care is daunting and scary; our focus is on improving the employee experience during high impact moments related to fertility-- helping save time, money and stress.

Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.

Phases uses AI to automate clinical trial operations, starting with patient recruitment. Our agent scans medical records and conducts human-like voice interviews to assess patient eligibility for clinical trials. Our vision is to run the entire clinical trial back-office with agents, getting drugs to market at a fraction of the time and cost it takes today.

Using infrared technology, we provide a non-invasive, painless, private, and accurate adjunct breast cancer screening in under 10 minutes. Our Eva Centers are located in shopping centers.

Flowly’s mobile app is the VR version of Calm with a focus on reducing chronic pain for 100 million Americans. Flowly subscribers receive a $5 VR headset and Heart Rate sensor that collects a user's biometric data like HR and HRV, and converts it to visualizations in virtual experiences that reduce pain by 46%. Flowly is backed by the National Institutes of Health.

Vena Vitals makes a small sticker that monitors blood pressure continuously. We've shown that it works in the operating room and is as accurate as the best tools doctors have today, at a fraction of the cost. We're a team of health tech scientists with multiple past startups and exits, and we've built products that have scaled to over 2M users.

Founded in 2010, Lygos is providing biotechnology solutions for today’s renewable chemical challenges. They engineer microbes to convert sugars into high-value, industrial chemicals, targeting compounds where biological production is cost-advantaged over petrochemical production.

Perlara 1.0 (Feb 2014 - Feb 2019) launched early R&D joint ventures called PerlQuests with highly motivated rare disease families, companies or impact investors. We screened gene-edited patient avatars for repurposable drugs in order to build a predictive R&D engine called ArkBase. We planned to monetize programs based on ArkBase predictions by selectively spinning out asset-centric clinical development NewCos. Perlara 1.5 (March 2019 - April 2020) was the transition to a one-person virtual clinical development company and when the epalrestat and aripiprazole repurposing trials were launched at Mayo Clinic for the treatment of PMM2-CDG and NGLY1-CDDG, respectively. Perlara 2.0 (May 2020 --> The first decentralized and distributed biotech

The Operating System for Health AI: we deploy, govern, and scale AI agents across healthcare organizations.

US hospitals and clinics are losing $125B every year due to delayed and inaccurate medical coding. Arintra is solving this problem by automating medical coding using AI and clinical NLP. Arintra converts a patient chart instantly into insurance claims with 96% accurate medical codes and zero human intervention. Arintra has processed more than 1.63 million claims this year across its 20+ provider clients that includes health systems and large physician groups. Through automation of these charts, Arintra has reduced undercoding by 11% and coding-related claim denials by 43%. Arintra is headquartered in Austin, Texas. Arintra is bi-directionally integrated with leading EHRs including Epic, Cerner, etc. to process patient charts directly from the EHR to create a direct-to-billing claim. This direct-to-billing claim includes precise E/M levels, CPT, ICD-10, HCC, HCPCS codes with appropriate modifiers and units. Both founders have PhDs in AI, significant ML and NLP experience, 60+ patents and publications, and a combined 20+ years of experience working at B2B companies and startups in Silicon Valley.

SmartSpot is a post Series-A stealth startup backed by Founders Fund and Khosla Ventures that uses computer vision to deliver an unparalleled fitness training experience to your home. Our unique hardware solution gives amazing trainers the ability to see their class participants in real time and deliver detailed advice that was previously only possible in person.

Think Function Health for Europe. We combine medical expertise and AI to transform regular blood testing into actionable insights to help people live healthier, longer. In four months in Paris, we've achieved $400K ARR, secured partnerships with France's leading lab networks, and partnered with key health influencers, proving our playbook works and scales rapidly. We are currently opening 4 new countries across Europe.

Nanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases. Our product allows drugs to be targeted to very specific areas of the body.

Instalab gives you direct access to all the preventative tests you need to do this year to stay on top of your health. Trusted by tens of thousands of top-performing founders, executives, and professional athletes.